Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage

Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage

BACKGROUND: The role of antidiabetic drugs in inpatient with COVID-19 and type 2 diabetes mellitus (T2DM) is usually considered in the context of target glycemiа maintaining. Except for insulin therapy sulfonylurea may be used in moderate COVID-19. The use of original gliclazide MR has advantages du...

Full description

Bibliographic Details
Main Authors: T. A. Nekrasova, L. G. Strongin, D. V. Belikina, E. S. Malysheva, A. A. Nekrasov
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-07-01
Series:Сахарный диабет
Subjects:
diabetes mellitus
covid-19
post-covid period
gliclazide mr
Online Access:https://www.dia-endojournals.ru/jour/article/view/13003

Internet

https://www.dia-endojournals.ru/jour/article/view/13003

Similar Items